{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:01:36Z","timestamp":1781938896859,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Creative Fusion Research Program"},{"DOI":"10.13039\/501100003714","name":"Korea Research Council of Fundamental Science and Technology","doi-asserted-by":"publisher","award":["CAP-12-1-KIST"],"award-info":[{"award-number":["CAP-12-1-KIST"]}],"id":[{"id":"10.13039\/501100003714","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Food & Drug Administration"},{"name":"Bio-Synergy Research Project","award":["NRF-2013M3A9C4078145"],"award-info":[{"award-number":["NRF-2013M3A9C4078145"]}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.chemphyslip.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T16:34:11Z","timestamp":1527525251000},"page":"69-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics"],"prefix":"10.1016","volume":"214","author":[{"given":"Hyunbeom","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Min","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-8273","authenticated-orcid":false,"given":"Joo-Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Hwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chemphyslip.2018.05.005_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","article-title":"Statin-induced myopathy: a review and update","volume":"10","author":"Abd","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.chemphyslip.2018.05.005_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10654-014-9910-7","article-title":"Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism","volume":"29","author":"Altmaier","year":"2014","journal-title":"Eur. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.chemphyslip.2018.05.005_bib0015","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1185\/03007990802321709","article-title":"Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins","volume":"24","author":"Bergheanu","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"issue":"Suppl. 2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0020","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.2337\/dcS13-2038","article-title":"Intolerance to statins: mechanisms and management","volume":"36","author":"Bitzur","year":"2013","journal-title":"Diab. Care"},{"issue":"8","key":"10.1016\/j.chemphyslip.2018.05.005_bib0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"J., A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"issue":"4","key":"10.1016\/j.chemphyslip.2018.05.005_bib0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00726-008-0182-y","article-title":"Changes in amino acid concentration in plasma and type I and type II fibres during resistance exercise and recovery in human subjects","volume":"37","author":"Blomstrand","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.chemphyslip.2018.05.005_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchromb.2013.10.029","article-title":"H.: Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma","volume":"944","author":"Choi","year":"2014","journal-title":"J. Chromatogr. B"},{"issue":"2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0040","first-page":"169","article-title":"M., Oxidative stress and mitochondrial dysfunction in fibromyalgia","volume":"31","author":"Cordero","year":"2010","journal-title":"Neuro Endocrinol. Lett."},{"issue":"11","key":"10.1016\/j.chemphyslip.2018.05.005_bib0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/ars.2015.6582","article-title":"A peculiar formula of essential amino acids prevents rosuvastatin myopathy in mice","volume":"25","author":"D'Antona","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.chemphyslip.2018.05.005_bib0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"Deans","year":"2005","journal-title":"Curr. Opin. Clin. Nutri. Metab. Care"},{"issue":"18","key":"10.1016\/j.chemphyslip.2018.05.005_bib0055","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.biomaterials.2004.09.064","article-title":"Phospholipase A2 pathway association with macrophage-mediated polycarbonate-urethane biodegradation","volume":"26","author":"Dinnes","year":"2005","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.chemphyslip.2018.05.005_bib0060","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1002\/rcm.4246","article-title":"Use of liquid chromatography\/tandem mass spectrometry and online databases for identification of phosphocholines and lysophosphatidylcholines in human red blood cells","volume":"23","author":"Fengguo","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.chemphyslip.2018.05.005_bib0065","doi-asserted-by":"crossref","DOI":"10.1186\/1743-7075-7-30","article-title":"Role of carnitine in disease","volume":"7","author":"Flanagan","year":"2010","journal-title":"Nutr. Metab."},{"issue":"3","key":"10.1016\/j.chemphyslip.2018.05.005_bib0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mas.20023","article-title":"Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples","volume":"24","author":"Han","year":"2005","journal-title":"Mass Spectrom. Rev."},{"issue":"4","key":"10.1016\/j.chemphyslip.2018.05.005_bib0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.1997.03550040069040","article-title":"H., Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials","volume":"278","author":"Hebert","year":"1997","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.chemphyslip.2018.05.005_bib0080","doi-asserted-by":"crossref","first-page":"e42866","DOI":"10.1371\/journal.pone.0042866","article-title":"A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class","volume":"7","author":"Hoffman","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.chemphyslip.2018.05.005_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI116945","article-title":"Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines","volume":"93","author":"Hrboticky","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/MCB.05603-11","article-title":"Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle","volume":"32","author":"Jheng","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.chemphyslip.2018.05.005_bib0095","first-page":"1952","article-title":"Effects of diet and simvastatin on fatty acid composition in hypercholesterolemic men","volume":"25","author":"Jula","year":"2005","journal-title":"A Random. Controll. Trial"},{"issue":"2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11306-010-0207-x","article-title":"Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study","volume":"6","author":"Kaddurah-Daouk","year":"2010","journal-title":"Metabolomics"},{"issue":"5","key":"10.1016\/j.chemphyslip.2018.05.005_bib0105","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0b013e32830e2774","article-title":"Drug-induced myopathies","volume":"21","author":"Klopstock","year":"2008","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0110","first-page":"351","article-title":"State of the art in muscle lipid diseases","volume":"29","author":"Liang","year":"2010","journal-title":"Acta Myol."},{"issue":"1","key":"10.1016\/j.chemphyslip.2018.05.005_bib0115","first-page":"2","article-title":"Evidence of lifestyle modification in the management of hypercholesterolemia","volume":"9","author":"Mannu","year":"2013","journal-title":"Curr. Cardiol. Revi."},{"issue":"12","key":"10.1016\/j.chemphyslip.2018.05.005_bib0120","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1194\/jlr.P061143","article-title":"Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia","volume":"56","author":"Meikle","year":"2015","journal-title":"J. Lipid Res."},{"issue":"3\u20134","key":"10.1016\/j.chemphyslip.2018.05.005_bib0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1615\/CritRevImmunol.v17.i3-4.10","article-title":"Regulatory functions of phospholipase A2","volume":"17","author":"Murakami","year":"1997","journal-title":"Crit. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.chemphyslip.2018.05.005_bib0130","doi-asserted-by":"crossref","first-page":"E2335","DOI":"10.1210\/jc.2014-1665","article-title":"Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome","volume":"99","author":"Ng","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.chemphyslip.2018.05.005_bib0135","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jcb.21247","article-title":"Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function","volume":"100","author":"Nicolson","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.chemphyslip.2018.05.005_bib0140","first-page":"35","article-title":"Mitochondrial dysfunction and chronic disease: treatment with natural supplements","volume":"13","author":"Nicolson","year":"2014","journal-title":"Integrative Med.: A Clin. J."},{"issue":"14","key":"10.1016\/j.chemphyslip.2018.05.005_bib0145","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.105.612630","volume":"113","author":"O\u2019Donoghue","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.chemphyslip.2018.05.005_bib0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1527-3466.2002.tb00099.x","article-title":"Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor","volume":"20","author":"Olsson","year":"2002","journal-title":"Cardiovasc. Drug Rev."},{"issue":"10","key":"10.1016\/j.chemphyslip.2018.05.005_bib0155","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00018-005-5406-7","article-title":"Lipid-lowering drugs","volume":"63","author":"Pahan","year":"2006","journal-title":"Cell. mol. Life Sci.: CMLS"},{"issue":"7","key":"10.1016\/j.chemphyslip.2018.05.005_bib0160","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1586\/14779072.6.7.971","article-title":"H., Statin myopathy as a metabolic muscle disease","volume":"6","author":"Phillips","year":"2008","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MCP.0b013e328336438d","article-title":"Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients","volume":"16","author":"Rabinovich","year":"2010","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"5","key":"10.1016\/j.chemphyslip.2018.05.005_bib0170","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ije\/dyw271","article-title":"Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future","volume":"45","author":"Rankin","year":"2016","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.chemphyslip.2018.05.005_bib0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/156720511795745401","article-title":"Mitochondria as a therapeutic target for aging and neurodegenerative diseases","volume":"8","author":"Reddy","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"12","key":"10.1016\/j.chemphyslip.2018.05.005_bib0180","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/rcm.3562","article-title":"A simple and universal method for the separation and identification of phospholipid molecular species","volume":"22","author":"Retra","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0185","first-page":"88","article-title":"Statins enhance arachidonic acid synthesis in hypercholesterolemic patients","volume":"11","author":"Rise","year":"2001","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.chemphyslip.2018.05.005_bib0190","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI112446","article-title":"Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency","volume":"77","author":"Roe","year":"1986","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.chemphyslip.2018.05.005_bib0195","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/ATVBAHA.107.147280","article-title":"Differential effect of hypolipidemic drugs on lipoprotein-Associated phospholipase A2","volume":"27","author":"Saougos","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.chemphyslip.2018.05.005_bib0200","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1055-9965.1185.13.7","article-title":"Lysophospholipids are potential biomarkers of ovarian cancer","volume":"13","author":"Sutphen","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers & Prevention"},{"issue":"1","key":"10.1016\/j.chemphyslip.2018.05.005_bib0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"D., Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.chemphyslip.2018.05.005_bib0210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2005-0873","article-title":"Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity","volume":"91","author":"Varastehpour","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"35","key":"10.1016\/j.chemphyslip.2018.05.005_bib0215","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.2174\/092986709789878265","article-title":"Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-Targeted antioxidants as potential therapy","volume":"16","author":"Victor","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.chemphyslip.2018.05.005_bib0220","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2015.12.060","article-title":"Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase","volume":"67","author":"W\u00fcrtz","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.chemphyslip.2018.05.005_bib0225","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1021\/ac0481001","article-title":"Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-Performance liquid Chromatography\/Electrospray mass spectrometry and multivariate statistical analysis","volume":"77","author":"Wang","year":"2005","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.chemphyslip.2018.05.005_bib0230","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.1041051","article-title":"Rosuvastatin (Crestor) and rhabdomyolysis","volume":"171","author":"Wooltorton","year":"2004","journal-title":"CMAJ: Canadian Medical Association Journal"},{"key":"10.1016\/j.chemphyslip.2018.05.005_bib0235","series-title":"Lipids in Health and Disease","first-page":"371","article-title":"Regulation of lipid metabolism by sphingolipids","author":"Worgall","year":"2008"},{"issue":"W1","key":"10.1016\/j.chemphyslip.2018.05.005_bib0240","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0\u2014making metabolomics more meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"10.1016\/j.chemphyslip.2018.05.005_bib0245","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1002\/rcm.4246","article-title":"Use of liquid chromatography\/tandem mass spectrometry and online databases for identification of phosphocholines and lysophosphatidylcholines in human red blood cells","volume":"23","author":"Xu","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"19","key":"10.1016\/j.chemphyslip.2018.05.005_bib0250","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10337-013-2429-3","article-title":"Targeted metabolomics of dried blood spot extracts","volume":"76","author":"Zukunft","year":"2013","journal-title":"Chromatographia"}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308418300331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308418300331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:49:34Z","timestamp":1661341774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308418300331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"alternative-id":["S0009308418300331"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2018.05.005","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}